Global COVID-19 In-Vitro Diagnostics Supply, Demand and Key Producers, 2023-2029

Page: 123

Published Date: 16 Mar 2023

Category: New Technology

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Related Reports
Product Tags

Description

The global COVID-19 In-Vitro Diagnostics market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

This report studies the global COVID-19 In-Vitro Diagnostics demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for COVID-19 In-Vitro Diagnostics, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of COVID-19 In-Vitro Diagnostics that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global COVID-19 In-Vitro Diagnostics total market, 2018-2029, (USD Million)
Global COVID-19 In-Vitro Diagnostics total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: COVID-19 In-Vitro Diagnostics total market, key domestic companies and share, (USD Million)
Global COVID-19 In-Vitro Diagnostics revenue by player and market share 2018-2023, (USD Million)
Global COVID-19 In-Vitro Diagnostics total market by Type, CAGR, 2018-2029, (USD Million)
Global COVID-19 In-Vitro Diagnostics total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global COVID-19 In-Vitro Diagnostics market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Cellex, Abbott, Roche, BioMedomics, BD, Henry Schein, Safecare Bio-Tech, Mayo Clinic Laboratories and Chembio Diagnostics, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World COVID-19 In-Vitro Diagnostics market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global COVID-19 In-Vitro Diagnostics Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global COVID-19 In-Vitro Diagnostics Market, Segmentation by Type
    Rapid Diagnostic Test (RDT)
    Enzyme Linked Immunosorbent Assay (ELISA)
    Neutralization Assay

Global COVID-19 In-Vitro Diagnostics Market, Segmentation by Application
    Home
    Hospital
    Clinical

Companies Profiled:
    Cellex
    Abbott
    Roche
    BioMedomics
    BD
    Henry Schein
    Safecare Bio-Tech
    Mayo Clinic Laboratories
    Chembio Diagnostics
    Mount Sinai Laboratory
    Ortho Clinical Diagnostics
    Zhejiang Orient Gene Biotech
    Innovita Biological Technology
    Guangzhou Wondfo Biotech
    Guangdong Hecin-Scientific
    Dynamiker Biotechnology (Tianjin)
    ADVAITE

Key Questions Answered
1. How big is the global COVID-19 In-Vitro Diagnostics market?
2. What is the demand of the global COVID-19 In-Vitro Diagnostics market?
3. What is the year over year growth of the global COVID-19 In-Vitro Diagnostics market?
4. What is the total value of the global COVID-19 In-Vitro Diagnostics market?
5. Who are the major players in the global COVID-19 In-Vitro Diagnostics market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 COVID-19 In-Vitro Diagnostics Introduction
    1.2 World COVID-19 In-Vitro Diagnostics Market Size & Forecast (2018 & 2022 & 2029)
    1.3 World COVID-19 In-Vitro Diagnostics Total Market by Region (by Headquarter Location)
        1.3.1 World COVID-19 In-Vitro Diagnostics Market Size by Region (2018-2029), (by Headquarter Location)
        1.3.2 United States COVID-19 In-Vitro Diagnostics Market Size (2018-2029)
        1.3.3 China COVID-19 In-Vitro Diagnostics Market Size (2018-2029)
        1.3.4 Europe COVID-19 In-Vitro Diagnostics Market Size (2018-2029)
        1.3.5 Japan COVID-19 In-Vitro Diagnostics Market Size (2018-2029)
        1.3.6 South Korea COVID-19 In-Vitro Diagnostics Market Size (2018-2029)
        1.3.7 ASEAN COVID-19 In-Vitro Diagnostics Market Size (2018-2029)
        1.3.8 India COVID-19 In-Vitro Diagnostics Market Size (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 COVID-19 In-Vitro Diagnostics Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 COVID-19 In-Vitro Diagnostics Major Market Trends
    1.5 Influence of COVID-19 and Russia-Ukraine War
        1.5.1 Influence of COVID-19
        1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
    2.1 World COVID-19 In-Vitro Diagnostics Consumption Value (2018-2029)
    2.2 World COVID-19 In-Vitro Diagnostics Consumption Value by Region
        2.2.1 World COVID-19 In-Vitro Diagnostics Consumption Value by Region (2018-2023)
        2.2.2 World COVID-19 In-Vitro Diagnostics Consumption Value Forecast by Region (2024-2029)
    2.3 United States COVID-19 In-Vitro Diagnostics Consumption Value (2018-2029)
    2.4 China COVID-19 In-Vitro Diagnostics Consumption Value (2018-2029)
    2.5 Europe COVID-19 In-Vitro Diagnostics Consumption Value (2018-2029)
    2.6 Japan COVID-19 In-Vitro Diagnostics Consumption Value (2018-2029)
    2.7 South Korea COVID-19 In-Vitro Diagnostics Consumption Value (2018-2029)
    2.8 ASEAN COVID-19 In-Vitro Diagnostics Consumption Value (2018-2029)
    2.9 India COVID-19 In-Vitro Diagnostics Consumption Value (2018-2029)

3 World COVID-19 In-Vitro Diagnostics Companies Competitive Analysis
    3.1 World COVID-19 In-Vitro Diagnostics Revenue by Player (2018-2023)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global COVID-19 In-Vitro Diagnostics Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for COVID-19 In-Vitro Diagnostics in 2022
        3.2.3 Global Concentration Ratios (CR8) for COVID-19 In-Vitro Diagnostics in 2022
    3.3 COVID-19 In-Vitro Diagnostics Company Evaluation Quadrant
    3.4 COVID-19 In-Vitro Diagnostics Market: Overall Company Footprint Analysis
        3.4.1 COVID-19 In-Vitro Diagnostics Market: Region Footprint
        3.4.2 COVID-19 In-Vitro Diagnostics Market: Company Product Type Footprint
        3.4.3 COVID-19 In-Vitro Diagnostics Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: COVID-19 In-Vitro Diagnostics Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: COVID-19 In-Vitro Diagnostics Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
        4.1.2 United States VS China: COVID-19 In-Vitro Diagnostics Revenue Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States Based Companies VS China Based Companies: COVID-19 In-Vitro Diagnostics Consumption Value Comparison
        4.2.1 United States VS China: COVID-19 In-Vitro Diagnostics Consumption Value Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: COVID-19 In-Vitro Diagnostics Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States Based COVID-19 In-Vitro Diagnostics Companies and Market Share, 2018-2023
        4.3.1 United States Based COVID-19 In-Vitro Diagnostics Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies COVID-19 In-Vitro Diagnostics Revenue, (2018-2023)
    4.4 China Based Companies COVID-19 In-Vitro Diagnostics Revenue and Market Share, 2018-2023
        4.4.1 China Based COVID-19 In-Vitro Diagnostics Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies COVID-19 In-Vitro Diagnostics Revenue, (2018-2023)
    4.5 Rest of World Based COVID-19 In-Vitro Diagnostics Companies and Market Share, 2018-2023
        4.5.1 Rest of World Based COVID-19 In-Vitro Diagnostics Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies COVID-19 In-Vitro Diagnostics Revenue, (2018-2023)

5 Market Analysis by Type
    5.1 World COVID-19 In-Vitro Diagnostics Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Rapid Diagnostic Test (RDT)
        5.2.2 Enzyme Linked Immunosorbent Assay (ELISA)
        5.2.3 Neutralization Assay
    5.3 Market Segment by Type
        5.3.1 World COVID-19 In-Vitro Diagnostics Market Size by Type (2018-2023)
        5.3.2 World COVID-19 In-Vitro Diagnostics Market Size by Type (2024-2029)
        5.3.3 World COVID-19 In-Vitro Diagnostics Market Size Market Share by Type (2018-2029)

6 Market Analysis by Application
    6.1 World COVID-19 In-Vitro Diagnostics Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Home
        6.2.2 Hospital
        6.2.3 Clinical
    6.3 Market Segment by Application
        6.3.1 World COVID-19 In-Vitro Diagnostics Market Size by Application (2018-2023)
        6.3.2 World COVID-19 In-Vitro Diagnostics Market Size by Application (2024-2029)
        6.3.3 World COVID-19 In-Vitro Diagnostics Market Size by Application (2018-2029)

7 Company Profiles
    7.1 Cellex
        7.1.1 Cellex Details
        7.1.2 Cellex Major Business
        7.1.3 Cellex COVID-19 In-Vitro Diagnostics Product and Services
        7.1.4 Cellex COVID-19 In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
        7.1.5 Cellex Recent Developments/Updates
        7.1.6 Cellex Competitive Strengths & Weaknesses
    7.2 Abbott
        7.2.1 Abbott Details
        7.2.2 Abbott Major Business
        7.2.3 Abbott COVID-19 In-Vitro Diagnostics Product and Services
        7.2.4 Abbott COVID-19 In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
        7.2.5 Abbott Recent Developments/Updates
        7.2.6 Abbott Competitive Strengths & Weaknesses
    7.3 Roche
        7.3.1 Roche Details
        7.3.2 Roche Major Business
        7.3.3 Roche COVID-19 In-Vitro Diagnostics Product and Services
        7.3.4 Roche COVID-19 In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
        7.3.5 Roche Recent Developments/Updates
        7.3.6 Roche Competitive Strengths & Weaknesses
    7.4 BioMedomics
        7.4.1 BioMedomics Details
        7.4.2 BioMedomics Major Business
        7.4.3 BioMedomics COVID-19 In-Vitro Diagnostics Product and Services
        7.4.4 BioMedomics COVID-19 In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
        7.4.5 BioMedomics Recent Developments/Updates
        7.4.6 BioMedomics Competitive Strengths & Weaknesses
    7.5 BD
        7.5.1 BD Details
        7.5.2 BD Major Business
        7.5.3 BD COVID-19 In-Vitro Diagnostics Product and Services
        7.5.4 BD COVID-19 In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
        7.5.5 BD Recent Developments/Updates
        7.5.6 BD Competitive Strengths & Weaknesses
    7.6 Henry Schein
        7.6.1 Henry Schein Details
        7.6.2 Henry Schein Major Business
        7.6.3 Henry Schein COVID-19 In-Vitro Diagnostics Product and Services
        7.6.4 Henry Schein COVID-19 In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
        7.6.5 Henry Schein Recent Developments/Updates
        7.6.6 Henry Schein Competitive Strengths & Weaknesses
    7.7 Safecare Bio-Tech
        7.7.1 Safecare Bio-Tech Details
        7.7.2 Safecare Bio-Tech Major Business
        7.7.3 Safecare Bio-Tech COVID-19 In-Vitro Diagnostics Product and Services
        7.7.4 Safecare Bio-Tech COVID-19 In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
        7.7.5 Safecare Bio-Tech Recent Developments/Updates
        7.7.6 Safecare Bio-Tech Competitive Strengths & Weaknesses
    7.8 Mayo Clinic Laboratories
        7.8.1 Mayo Clinic Laboratories Details
        7.8.2 Mayo Clinic Laboratories Major Business
        7.8.3 Mayo Clinic Laboratories COVID-19 In-Vitro Diagnostics Product and Services
        7.8.4 Mayo Clinic Laboratories COVID-19 In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
        7.8.5 Mayo Clinic Laboratories Recent Developments/Updates
        7.8.6 Mayo Clinic Laboratories Competitive Strengths & Weaknesses
    7.9 Chembio Diagnostics
        7.9.1 Chembio Diagnostics Details
        7.9.2 Chembio Diagnostics Major Business
        7.9.3 Chembio Diagnostics COVID-19 In-Vitro Diagnostics Product and Services
        7.9.4 Chembio Diagnostics COVID-19 In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
        7.9.5 Chembio Diagnostics Recent Developments/Updates
        7.9.6 Chembio Diagnostics Competitive Strengths & Weaknesses
    7.10 Mount Sinai Laboratory
        7.10.1 Mount Sinai Laboratory Details
        7.10.2 Mount Sinai Laboratory Major Business
        7.10.3 Mount Sinai Laboratory COVID-19 In-Vitro Diagnostics Product and Services
        7.10.4 Mount Sinai Laboratory COVID-19 In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
        7.10.5 Mount Sinai Laboratory Recent Developments/Updates
        7.10.6 Mount Sinai Laboratory Competitive Strengths & Weaknesses
    7.11 Ortho Clinical Diagnostics
        7.11.1 Ortho Clinical Diagnostics Details
        7.11.2 Ortho Clinical Diagnostics Major Business
        7.11.3 Ortho Clinical Diagnostics COVID-19 In-Vitro Diagnostics Product and Services
        7.11.4 Ortho Clinical Diagnostics COVID-19 In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
        7.11.5 Ortho Clinical Diagnostics Recent Developments/Updates
        7.11.6 Ortho Clinical Diagnostics Competitive Strengths & Weaknesses
    7.12 Zhejiang Orient Gene Biotech
        7.12.1 Zhejiang Orient Gene Biotech Details
        7.12.2 Zhejiang Orient Gene Biotech Major Business
        7.12.3 Zhejiang Orient Gene Biotech COVID-19 In-Vitro Diagnostics Product and Services
        7.12.4 Zhejiang Orient Gene Biotech COVID-19 In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
        7.12.5 Zhejiang Orient Gene Biotech Recent Developments/Updates
        7.12.6 Zhejiang Orient Gene Biotech Competitive Strengths & Weaknesses
    7.13 Innovita Biological Technology
        7.13.1 Innovita Biological Technology Details
        7.13.2 Innovita Biological Technology Major Business
        7.13.3 Innovita Biological Technology COVID-19 In-Vitro Diagnostics Product and Services
        7.13.4 Innovita Biological Technology COVID-19 In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
        7.13.5 Innovita Biological Technology Recent Developments/Updates
        7.13.6 Innovita Biological Technology Competitive Strengths & Weaknesses
    7.14 Guangzhou Wondfo Biotech
        7.14.1 Guangzhou Wondfo Biotech Details
        7.14.2 Guangzhou Wondfo Biotech Major Business
        7.14.3 Guangzhou Wondfo Biotech COVID-19 In-Vitro Diagnostics Product and Services
        7.14.4 Guangzhou Wondfo Biotech COVID-19 In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
        7.14.5 Guangzhou Wondfo Biotech Recent Developments/Updates
        7.14.6 Guangzhou Wondfo Biotech Competitive Strengths & Weaknesses
    7.15 Guangdong Hecin-Scientific
        7.15.1 Guangdong Hecin-Scientific Details
        7.15.2 Guangdong Hecin-Scientific Major Business
        7.15.3 Guangdong Hecin-Scientific COVID-19 In-Vitro Diagnostics Product and Services
        7.15.4 Guangdong Hecin-Scientific COVID-19 In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
        7.15.5 Guangdong Hecin-Scientific Recent Developments/Updates
        7.15.6 Guangdong Hecin-Scientific Competitive Strengths & Weaknesses
    7.16 Dynamiker Biotechnology (Tianjin)
        7.16.1 Dynamiker Biotechnology (Tianjin) Details
        7.16.2 Dynamiker Biotechnology (Tianjin) Major Business
        7.16.3 Dynamiker Biotechnology (Tianjin) COVID-19 In-Vitro Diagnostics Product and Services
        7.16.4 Dynamiker Biotechnology (Tianjin) COVID-19 In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
        7.16.5 Dynamiker Biotechnology (Tianjin) Recent Developments/Updates
        7.16.6 Dynamiker Biotechnology (Tianjin) Competitive Strengths & Weaknesses
    7.17 ADVAITE
        7.17.1 ADVAITE Details
        7.17.2 ADVAITE Major Business
        7.17.3 ADVAITE COVID-19 In-Vitro Diagnostics Product and Services
        7.17.4 ADVAITE COVID-19 In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
        7.17.5 ADVAITE Recent Developments/Updates
        7.17.6 ADVAITE Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 COVID-19 In-Vitro Diagnostics Industry Chain
    8.2 COVID-19 In-Vitro Diagnostics Upstream Analysis
    8.3 COVID-19 In-Vitro Diagnostics Midstream Analysis
    8.4 COVID-19 In-Vitro Diagnostics Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World COVID-19 In-Vitro Diagnostics Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
    Table 2. World COVID-19 In-Vitro Diagnostics Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
    Table 3. World COVID-19 In-Vitro Diagnostics Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
    Table 4. World COVID-19 In-Vitro Diagnostics Revenue Market Share by Region (2018-2023), (by Headquarter Location)
    Table 5. World COVID-19 In-Vitro Diagnostics Revenue Market Share by Region (2024-2029), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World COVID-19 In-Vitro Diagnostics Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
    Table 8. World COVID-19 In-Vitro Diagnostics Consumption Value by Region (2018-2023) & (USD Million)
    Table 9. World COVID-19 In-Vitro Diagnostics Consumption Value Forecast by Region (2024-2029) & (USD Million)
    Table 10. World COVID-19 In-Vitro Diagnostics Revenue by Player (2018-2023) & (USD Million)
    Table 11. Revenue Market Share of Key COVID-19 In-Vitro Diagnostics Players in 2022
    Table 12. World COVID-19 In-Vitro Diagnostics Industry Rank of Major Player, Based on Revenue in 2022
    Table 13. Global COVID-19 In-Vitro Diagnostics Company Evaluation Quadrant
    Table 14. Head Office of Key COVID-19 In-Vitro Diagnostics Player
    Table 15. COVID-19 In-Vitro Diagnostics Market: Company Product Type Footprint
    Table 16. COVID-19 In-Vitro Diagnostics Market: Company Product Application Footprint
    Table 17. COVID-19 In-Vitro Diagnostics Mergers & Acquisitions Activity
    Table 18. United States VS China COVID-19 In-Vitro Diagnostics Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 19. United States VS China COVID-19 In-Vitro Diagnostics Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 20. United States Based COVID-19 In-Vitro Diagnostics Companies, Headquarters (States, Country)
    Table 21. United States Based Companies COVID-19 In-Vitro Diagnostics Revenue, (2018-2023) & (USD Million)
    Table 22. United States Based Companies COVID-19 In-Vitro Diagnostics Revenue Market Share (2018-2023)
    Table 23. China Based COVID-19 In-Vitro Diagnostics Companies, Headquarters (Province, Country)
    Table 24. China Based Companies COVID-19 In-Vitro Diagnostics Revenue, (2018-2023) & (USD Million)
    Table 25. China Based Companies COVID-19 In-Vitro Diagnostics Revenue Market Share (2018-2023)
    Table 26. Rest of World Based COVID-19 In-Vitro Diagnostics Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies COVID-19 In-Vitro Diagnostics Revenue, (2018-2023) & (USD Million)
    Table 28. Rest of World Based Companies COVID-19 In-Vitro Diagnostics Revenue Market Share (2018-2023)
    Table 29. World COVID-19 In-Vitro Diagnostics Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Table 30. World COVID-19 In-Vitro Diagnostics Market Size by Type (2018-2023) & (USD Million)
    Table 31. World COVID-19 In-Vitro Diagnostics Market Size by Type (2024-2029) & (USD Million)
    Table 32. World COVID-19 In-Vitro Diagnostics Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Table 33. World COVID-19 In-Vitro Diagnostics Market Size by Application (2018-2023) & (USD Million)
    Table 34. World COVID-19 In-Vitro Diagnostics Market Size by Application (2024-2029) & (USD Million)
    Table 35. Cellex Basic Information, Area Served and Competitors
    Table 36. Cellex Major Business
    Table 37. Cellex COVID-19 In-Vitro Diagnostics Product and Services
    Table 38. Cellex COVID-19 In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 39. Cellex Recent Developments/Updates
    Table 40. Cellex Competitive Strengths & Weaknesses
    Table 41. Abbott Basic Information, Area Served and Competitors
    Table 42. Abbott Major Business
    Table 43. Abbott COVID-19 In-Vitro Diagnostics Product and Services
    Table 44. Abbott COVID-19 In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 45. Abbott Recent Developments/Updates
    Table 46. Abbott Competitive Strengths & Weaknesses
    Table 47. Roche Basic Information, Area Served and Competitors
    Table 48. Roche Major Business
    Table 49. Roche COVID-19 In-Vitro Diagnostics Product and Services
    Table 50. Roche COVID-19 In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 51. Roche Recent Developments/Updates
    Table 52. Roche Competitive Strengths & Weaknesses
    Table 53. BioMedomics Basic Information, Area Served and Competitors
    Table 54. BioMedomics Major Business
    Table 55. BioMedomics COVID-19 In-Vitro Diagnostics Product and Services
    Table 56. BioMedomics COVID-19 In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 57. BioMedomics Recent Developments/Updates
    Table 58. BioMedomics Competitive Strengths & Weaknesses
    Table 59. BD Basic Information, Area Served and Competitors
    Table 60. BD Major Business
    Table 61. BD COVID-19 In-Vitro Diagnostics Product and Services
    Table 62. BD COVID-19 In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 63. BD Recent Developments/Updates
    Table 64. BD Competitive Strengths & Weaknesses
    Table 65. Henry Schein Basic Information, Area Served and Competitors
    Table 66. Henry Schein Major Business
    Table 67. Henry Schein COVID-19 In-Vitro Diagnostics Product and Services
    Table 68. Henry Schein COVID-19 In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 69. Henry Schein Recent Developments/Updates
    Table 70. Henry Schein Competitive Strengths & Weaknesses
    Table 71. Safecare Bio-Tech Basic Information, Area Served and Competitors
    Table 72. Safecare Bio-Tech Major Business
    Table 73. Safecare Bio-Tech COVID-19 In-Vitro Diagnostics Product and Services
    Table 74. Safecare Bio-Tech COVID-19 In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 75. Safecare Bio-Tech Recent Developments/Updates
    Table 76. Safecare Bio-Tech Competitive Strengths & Weaknesses
    Table 77. Mayo Clinic Laboratories Basic Information, Area Served and Competitors
    Table 78. Mayo Clinic Laboratories Major Business
    Table 79. Mayo Clinic Laboratories COVID-19 In-Vitro Diagnostics Product and Services
    Table 80. Mayo Clinic Laboratories COVID-19 In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 81. Mayo Clinic Laboratories Recent Developments/Updates
    Table 82. Mayo Clinic Laboratories Competitive Strengths & Weaknesses
    Table 83. Chembio Diagnostics Basic Information, Area Served and Competitors
    Table 84. Chembio Diagnostics Major Business
    Table 85. Chembio Diagnostics COVID-19 In-Vitro Diagnostics Product and Services
    Table 86. Chembio Diagnostics COVID-19 In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 87. Chembio Diagnostics Recent Developments/Updates
    Table 88. Chembio Diagnostics Competitive Strengths & Weaknesses
    Table 89. Mount Sinai Laboratory Basic Information, Area Served and Competitors
    Table 90. Mount Sinai Laboratory Major Business
    Table 91. Mount Sinai Laboratory COVID-19 In-Vitro Diagnostics Product and Services
    Table 92. Mount Sinai Laboratory COVID-19 In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 93. Mount Sinai Laboratory Recent Developments/Updates
    Table 94. Mount Sinai Laboratory Competitive Strengths & Weaknesses
    Table 95. Ortho Clinical Diagnostics Basic Information, Area Served and Competitors
    Table 96. Ortho Clinical Diagnostics Major Business
    Table 97. Ortho Clinical Diagnostics COVID-19 In-Vitro Diagnostics Product and Services
    Table 98. Ortho Clinical Diagnostics COVID-19 In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 99. Ortho Clinical Diagnostics Recent Developments/Updates
    Table 100. Ortho Clinical Diagnostics Competitive Strengths & Weaknesses
    Table 101. Zhejiang Orient Gene Biotech Basic Information, Area Served and Competitors
    Table 102. Zhejiang Orient Gene Biotech Major Business
    Table 103. Zhejiang Orient Gene Biotech COVID-19 In-Vitro Diagnostics Product and Services
    Table 104. Zhejiang Orient Gene Biotech COVID-19 In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 105. Zhejiang Orient Gene Biotech Recent Developments/Updates
    Table 106. Zhejiang Orient Gene Biotech Competitive Strengths & Weaknesses
    Table 107. Innovita Biological Technology Basic Information, Area Served and Competitors
    Table 108. Innovita Biological Technology Major Business
    Table 109. Innovita Biological Technology COVID-19 In-Vitro Diagnostics Product and Services
    Table 110. Innovita Biological Technology COVID-19 In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 111. Innovita Biological Technology Recent Developments/Updates
    Table 112. Innovita Biological Technology Competitive Strengths & Weaknesses
    Table 113. Guangzhou Wondfo Biotech Basic Information, Area Served and Competitors
    Table 114. Guangzhou Wondfo Biotech Major Business
    Table 115. Guangzhou Wondfo Biotech COVID-19 In-Vitro Diagnostics Product and Services
    Table 116. Guangzhou Wondfo Biotech COVID-19 In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 117. Guangzhou Wondfo Biotech Recent Developments/Updates
    Table 118. Guangzhou Wondfo Biotech Competitive Strengths & Weaknesses
    Table 119. Guangdong Hecin-Scientific Basic Information, Area Served and Competitors
    Table 120. Guangdong Hecin-Scientific Major Business
    Table 121. Guangdong Hecin-Scientific COVID-19 In-Vitro Diagnostics Product and Services
    Table 122. Guangdong Hecin-Scientific COVID-19 In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 123. Guangdong Hecin-Scientific Recent Developments/Updates
    Table 124. Guangdong Hecin-Scientific Competitive Strengths & Weaknesses
    Table 125. Dynamiker Biotechnology (Tianjin) Basic Information, Area Served and Competitors
    Table 126. Dynamiker Biotechnology (Tianjin) Major Business
    Table 127. Dynamiker Biotechnology (Tianjin) COVID-19 In-Vitro Diagnostics Product and Services
    Table 128. Dynamiker Biotechnology (Tianjin) COVID-19 In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 129. Dynamiker Biotechnology (Tianjin) Recent Developments/Updates
    Table 130. ADVAITE Basic Information, Area Served and Competitors
    Table 131. ADVAITE Major Business
    Table 132. ADVAITE COVID-19 In-Vitro Diagnostics Product and Services
    Table 133. ADVAITE COVID-19 In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 134. Global Key Players of COVID-19 In-Vitro Diagnostics Upstream (Raw Materials)
    Table 135. COVID-19 In-Vitro Diagnostics Typical Customers
List of Figure
    Figure 1. COVID-19 In-Vitro Diagnostics Picture
    Figure 2. World COVID-19 In-Vitro Diagnostics Total Market Size: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World COVID-19 In-Vitro Diagnostics Total Market Size (2018-2029) & (USD Million)
    Figure 4. World COVID-19 In-Vitro Diagnostics Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
    Figure 5. World COVID-19 In-Vitro Diagnostics Revenue Market Share by Region (2018-2029), (by Headquarter Location)
    Figure 6. United States Based Company COVID-19 In-Vitro Diagnostics Revenue (2018-2029) & (USD Million)
    Figure 7. China Based Company COVID-19 In-Vitro Diagnostics Revenue (2018-2029) & (USD Million)
    Figure 8. Europe Based Company COVID-19 In-Vitro Diagnostics Revenue (2018-2029) & (USD Million)
    Figure 9. Japan Based Company COVID-19 In-Vitro Diagnostics Revenue (2018-2029) & (USD Million)
    Figure 10. South Korea Based Company COVID-19 In-Vitro Diagnostics Revenue (2018-2029) & (USD Million)
    Figure 11. ASEAN Based Company COVID-19 In-Vitro Diagnostics Revenue (2018-2029) & (USD Million)
    Figure 12. India Based Company COVID-19 In-Vitro Diagnostics Revenue (2018-2029) & (USD Million)
    Figure 13. COVID-19 In-Vitro Diagnostics Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World COVID-19 In-Vitro Diagnostics Consumption Value (2018-2029) & (USD Million)
    Figure 16. World COVID-19 In-Vitro Diagnostics Consumption Value Market Share by Region (2018-2029)
    Figure 17. United States COVID-19 In-Vitro Diagnostics Consumption Value (2018-2029) & (USD Million)
    Figure 18. China COVID-19 In-Vitro Diagnostics Consumption Value (2018-2029) & (USD Million)
    Figure 19. Europe COVID-19 In-Vitro Diagnostics Consumption Value (2018-2029) & (USD Million)
    Figure 20. Japan COVID-19 In-Vitro Diagnostics Consumption Value (2018-2029) & (USD Million)
    Figure 21. South Korea COVID-19 In-Vitro Diagnostics Consumption Value (2018-2029) & (USD Million)
    Figure 22. ASEAN COVID-19 In-Vitro Diagnostics Consumption Value (2018-2029) & (USD Million)
    Figure 23. India COVID-19 In-Vitro Diagnostics Consumption Value (2018-2029) & (USD Million)
    Figure 24. Producer Shipments of COVID-19 In-Vitro Diagnostics by Player Revenue ($MM) and Market Share (%): 2022
    Figure 25. Global Four-firm Concentration Ratios (CR4) for COVID-19 In-Vitro Diagnostics Markets in 2022
    Figure 26. Global Four-firm Concentration Ratios (CR8) for COVID-19 In-Vitro Diagnostics Markets in 2022
    Figure 27. United States VS China: COVID-19 In-Vitro Diagnostics Revenue Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: COVID-19 In-Vitro Diagnostics Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. World COVID-19 In-Vitro Diagnostics Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Figure 30. World COVID-19 In-Vitro Diagnostics Market Size Market Share by Type in 2022
    Figure 31. Rapid Diagnostic Test (RDT)
    Figure 32. Enzyme Linked Immunosorbent Assay (ELISA)
    Figure 33. Neutralization Assay
    Figure 34. World COVID-19 In-Vitro Diagnostics Market Size Market Share by Type (2018-2029)
    Figure 35. World COVID-19 In-Vitro Diagnostics Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Figure 36. World COVID-19 In-Vitro Diagnostics Market Size Market Share by Application in 2022
    Figure 37. Home
    Figure 38. Hospital
    Figure 39. Clinical
    Figure 40. COVID-19 In-Vitro Diagnostics Industrial Chain
    Figure 41. Methodology
    Figure 42. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Related Reports

Global COVID-19 In-Vitro Diagnostics Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Global COVID-19 In-Vitro Diagnostics Market 2023 by Company, Regions, Type and Application, Forecast to 2029

date 06 Jan 2023

date New Technology

The COVID-19 In-Vitro Diagnostics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Global COVID-19 In-Vitro Diagnostics Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global COVID-19 In-Vitro Diagnostics Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 17 Jan 2024

date New Technology

According to our latest research, the global COVID-19 In-Vitro Diagnostics market size will reach USD million in 2030, growing at a CAGR of % over the analysis period.

Product Tags

COVID-19 In-Vitro Diagnostics

Ecobricks

Space Mining

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>